Cells were treated with GV (1 μmol/L), methotrexate (10 μmol/L), methotrexate and GV, or dimethyl sulfoxide (DMSO) (1 μmol/L) for 24 hours; apoptosis was detected by flow cytometry. There was no significant difference (P > .05) between methotrexate and GV vs GV treatment in SeAx cells. The Jurkat T-cell acute lymphoblastic luekemia line was included for comparison.
aP < .001 for methotrexate and GV treatment vs DMSO, methotrexate, and GV.
bP < .001 for methotrexate and GV treatment vs DMSO and methotrexate.